Tuesday, June 30, 2026 Live from SEC EDGAR

The Wire Search Saved

···

FilingIndex

AI-powered intelligence over every SEC filing. Search in plain English. Free.

Browse

Sectors
Themes
Search

Data

SEC EDGAR
About

Legal

Privacy
Disclaimer

© 2026 FilingIndex · Data sourced from SEC EDGAR (public domain).Not investment advice.

NGEN — NERVGEN PHARMA CORP. SEC Filings | FilingIndex

NGENNasdaq

NERVGEN PHARMA CORP.

Pharmaceutical Preparations · A1 · CIK 1751912

Develops neuroreparative therapeutics for spinal cord injury and other neurologic conditions

+ Watch View on EDGAR ↗

$204M

Market cap

$1.96

Last close

+4.8%

1D

-8.4%

5D

806K

Volume

Price · last 39 sessions-46.4%

May 4L $1.73 · H $3.89Jun 29

10

Total filings

Jun 1, 2026

Last filing

12/31

Fiscal year end

6-KFORM 6-KJun 1, 2026 6-KFORM 6-KMay 26, 2026 6-KFORM 6-KMay 22, 2026 6-KFORM 6-KMay 18, 2026 6-KFORM 6-KMay 15, 2026 6-KFORM 6-K

Similar companies

Comparable business profile · signals at a glance

PEPGPepGen Inc.$101.7M+4.7%NGNENeurogene Inc.$459.8M+0.8%RGNXREGENXBIO Inc.$344.3M+12.9%NMRANeumora Therapeutics, Inc.$329.8M+4.9%AXGNAxogen, Inc.

Apr 27, 2026

6-KFORM 6-KMar 13, 2026

6-KFORM 6-KFeb 13, 2026

6-KFORM 6-KFeb 10, 2026

6-KFORM 6-KJan 8, 2026

$2.3B

-0.5%

CTNMContineum Therapeutics, Inc.$444.2M+5.7%